Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)

Clinical trial NCT02040623 · COMPLETED

Trial details

NCT number: NCT02040623
Sponsor: Rigel Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Graft-versus-host Disease

Start date: 2014-03-01
Primary completion: 2016-07-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.